California Public Employees Retirement System’s BioCryst Pharmaceuticals BCRX Stock Holding History

California Public Employees Retirement System’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-359,300	Closed	-$3.65M	–	1706
2021 Q1	$3.65M	Sell	359,300 -33,009	-8%	-$340K	﹤0.01%	1619
2020 Q4	$2.92M	Sell	392,309 -7,500	-2%	-$38.7K	﹤0.01%	1760
2020 Q3	$1.37M	Buy	399,809 +53,342	+15%	+$229K	﹤0.01%	2058
2020 Q2	$1.65M	Buy	346,467 +14,812	+4%	+$59.2K	﹤0.01%	1905
2020 Q1	$663K	Buy	331,655 +99,200	+43%	+$273K	﹤0.01%	2245
2019 Q4	$802K	Buy	232,455 +92,141	+66%	+$232K	﹤0.01%	2499
2019 Q3	$402K	Buy	140,314 +20,693	+17%	+$64.4K	﹤0.01%	2654
2019 Q2	$453K	Buy	119,621 +7,100	+6%	+$42.7K	﹤0.01%	2576
2019 Q1	$916K	Sell	112,521 -36,152	-24%	-$310K	﹤0.01%	2269
2018 Q4	$1.2M	Buy	148,673 +28,852	+24%	+$224K	﹤0.01%	2079
2018 Q3	$914K	Buy	119,821 +10,421	+10%	+$70K	﹤0.01%	2381
2018 Q2	$627K	Sell	109,400 -8,900	-8%	-$49K	﹤0.01%	2547
2018 Q1	$564K	Hold	118,300	–	–	﹤0.01%	2585
2017 Q4	$581K	Hold	118,300	–	–	﹤0.01%	2590
2017 Q3	$620K	Hold	118,300	–	–	﹤0.01%	2560
2017 Q2	$658K	Hold	118,300	–	–	﹤0.01%	2508
2017 Q1	$994K	Sell	118,300 -5,100	-4%	-$35.5K	﹤0.01%	2285
2016 Q4	$781K	Hold	123,400	–	–	﹤0.01%	2465
2016 Q3	$544K	Sell	123,400 -8,600	-7%	-$34.4K	﹤0.01%	2682
2016 Q2	$375K	Sell	132,000 -4,200	-3%	-$13K	﹤0.01%	2855
2016 Q1	$385K	Sell	136,200 -8,300	-6%	-$36.8K	﹤0.01%	2839
2015 Q4	$1.49M	Hold	144,500	–	–	﹤0.01%	2119
2015 Q3	$1.65M	Hold	144,500	–	–	﹤0.01%	2038
2015 Q2	$2.16M	Sell	144,500 -16,000	-10%	-$182K	﹤0.01%	1997
2015 Q1	$1.77M	Hold	160,500	–	–	﹤0.01%	2211
2014 Q4	$1.77M	Buy	160,500 +16,000	+11%	+$177K	﹤0.01%	2211
2014 Q3	$1.41M	Hold	144,500	–	–	﹤0.01%	2284
2014 Q2	$1.84M	Hold	144,500	–	–	﹤0.01%	2155
2014 Q1	$1.37M	Hold	144,500	–	–	﹤0.01%	2321
2013 Q4	$1.09M	Hold	144,500	–	–	﹤0.01%	2505
2013 Q3	$1.05M	Sell	144,500 -2,000	-1%	-$10.1K	﹤0.01%	2359
2013 Q2	$227K	Buy	+146,500	New	+$253K	﹤0.01%	3048

Other funds holding BCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

California Public Employees Retirement System's BCRX Position: Q2 2021 in Review

California Public Employees Retirement System sold out of BioCryst Pharmaceuticals (BCRX) in Q2 2021, closing a stake of 359,300 shares — an estimated $3.65M sold.

California Public Employees Retirement System first reported a position in BCRX in Q2 2013 and held it in 32 quarters. The position peaked at $3.65M in Q1 2021. 195 funds tracked by Wall St. Rank hold BCRX as of Q2 2021.

California Public Employees Retirement System reported no remaining BioCryst Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
California Public Employees Retirement System sold 359,300 BioCryst Pharmaceuticals shares in Q2 2021, an estimated $3.65M.
California Public Employees Retirement System first reported a position in BioCryst Pharmaceuticals in Q2 2013 and held it in 32 quarters.
California Public Employees Retirement System's BioCryst Pharmaceuticals position peaked at $3.65M in Q1 2021.
195 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.